Autoimmune Dilated Cardiomyopathy

Udi Nussinovitch, Yehuda Shoenfeld, Abihai Lucas Hernández

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Dilated cardiomyopathy (DCM) is a prevalent and complex heart condition characterized by the dilation and impaired contractility of both left and right ventricles, often leading to heart failure and transplantation. While some cases of DCM are associated with acute and chronic inflammation, idiopathic DCM is diagnosed after ruling out secondary causes (genetics, infections, toxins, and autoimmune conditions). Autoimmune factors play a significant role in the pathogenesis of DCM, particularly in cases of autoimmune DCM (ADCM). Antibodies targeting mitochondrial proteins and cardiac myosin, complement activation, and cytokines contribute to myocardial damage. Clinical manifestations of DCM typically present as heart failure symptoms, including palpitations, chest pain, and shortness of breath. Here, we propose a diagnosis criterion for ADCM. Patients with established ADCM will gain the greatest beneficial effect of immunosuppressive and immunomodulating treatment.

Original languageEnglish
Title of host publicationAutoimmune Disease Diagnosis
Subtitle of host publicationSystemic and Organ-specific Diseases, Second Edition
PublisherSpringer Nature
Pages525-529
Number of pages5
ISBN (Electronic)9783031698958
ISBN (Print)9783031698941
DOIs
StatePublished - 1 Jan 2025
Externally publishedYes

Keywords

  • Anti-a-myosin heavy chain
  • Anti-b1 adrenergic receptor
  • Autoantibodies
  • Dilated cardiomyopathy (DCM)
  • Left ventricular end-diastolic volume (LVEDV)

Fingerprint

Dive into the research topics of 'Autoimmune Dilated Cardiomyopathy'. Together they form a unique fingerprint.

Cite this